168 related articles for article (PubMed ID: 33029299)
1. SPRY4-IT1 promotes survival of colorectal cancer cells through regulating PDK1-mediated glycolysis.
Liu S; Huang F; Ye Q; Li Y; Chen J; Huang H
Anim Cells Syst (Seoul); 2020 Jun; 24(4):220-227. PubMed ID: 33029299
[TBL] [Abstract][Full Text] [Related]
2. PDK1-stabilized LncRNA SPRY4-IT1 promotes breast cancer progression via activating NF-κB signaling pathway.
Zhang Y; Chen H; Yuan R; Wang Y; Zhang D; Zeng Q; Jiang W; Zhang R; Chen T; Chai C; Guo B
Mol Carcinog; 2023 Jul; 62(7):1009-1024. PubMed ID: 37042573
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA SPRY4-IT1 promotes malignant development of colorectal cancer by targeting epithelial-mesenchymal transition.
Cao D; Ding Q; Yu W; Gao M; Wang Y
Onco Targets Ther; 2016; 9():5417-25. PubMed ID: 27621655
[TBL] [Abstract][Full Text] [Related]
4. Up-Regulated Expression of SPRY4-IT1 Predicts Poor Prognosis in Colorectal Cancer.
Tan W; Song ZZ; Xu Q; Qu X; Li Z; Wang Y; Yu Q; Wang S
Med Sci Monit; 2017 Jan; 23():309-314. PubMed ID: 28099409
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA SPRY4-IT1 pormotes colorectal cancer metastasis by regulate epithelial-mesenchymal transition.
Shen F; Cai WS; Feng Z; Chen JW; Feng JH; Liu QC; Fang YP; Li KP; Xiao HQ; Cao J; Xu B
Oncotarget; 2017 Feb; 8(9):14479-14486. PubMed ID: 27391336
[TBL] [Abstract][Full Text] [Related]
6. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion.
Khaitan D; Dinger ME; Mazar J; Crawford J; Smith MA; Mattick JS; Perera RJ
Cancer Res; 2011 Jun; 71(11):3852-62. PubMed ID: 21558391
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
Peng W; Wu G; Fan H; Wu J; Feng J
Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
[TBL] [Abstract][Full Text] [Related]
9. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
10. Interference from LncRNA SPRY4-IT1 restrains the proliferation, migration, and invasion of melanoma cells through inactivating MAPK pathway by up-regulating miR-22-3p.
Li Z; Tang X; Duan S
Int J Clin Exp Pathol; 2019; 12(2):477-487. PubMed ID: 31933852
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of long non-coding RNA
Zhang X; Chi Q; Zhao Z
Oncotarget; 2017 Aug; 8(31):51058-51065. PubMed ID: 28881629
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA
Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA SPRY4-IT1 promotes proliferation and invasion by acting as a ceRNA of miR-101-3p in colorectal cancer cells.
Jin J; Chu Z; Ma P; Meng Y; Yang Y
Tumour Biol; 2017 Jul; 39(7):1010428317716250. PubMed ID: 28720069
[TBL] [Abstract][Full Text] [Related]
15. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
Xie M; Nie FQ; Sun M; Xia R; Liu YW; Zhou P; De W; Liu XH
J Transl Med; 2015 Aug; 13():250. PubMed ID: 26238992
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2.
Liu D; Li Y; Luo G; Xiao X; Tao D; Wu X; Wang M; Huang C; Wang L; Zeng F; Jiang G
Cancer Lett; 2017 Mar; 388():281-291. PubMed ID: 27998761
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SPRY4-IT was concerned with the poor prognosis and contributed to the progression of thyroid cancer.
Zhou H; Sun Z; Li S; Wang X; Zhou X
Cancer Gene Ther; 2018 Feb; 25(1-2):39-46. PubMed ID: 29234152
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
19. SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers.
Li J; Chen Y; Chen Z; He A; Xie H; Zhang Q; Cai Z; Liu Y; Huang W
Tumour Biol; 2017 Jun; 39(6):1010428317711406. PubMed ID: 28651500
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA SPRY4-IT1 promotes the proliferation and invasion of U251 cells through upregulation of SKA2.
He XJ; Bian EB; Ma CC; Wang C; Wang HL; Zhao B
Oncol Lett; 2018 Mar; 15(3):3977-3984. PubMed ID: 29467908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
